NCDR Study: Minority of Patients With MI and AFib Receive Guideline-Recommended Antithrombotic Therapy – American College of Cardiology
Adults with myocardial infarction (MI) who also have atrial fibrillation (AFib) are at risk of a recurrent ischemic event, but a minority of these patients receive antiplatelet and anticoagulant therapy for the guideline-recommended duration, according to a study published Dec. 21 in Circulation: Cardiovascular Interventions. Using data from ACC’s Chest Pain – MI Registry, Alexander C….
